Y Combinator Partner discusses biotech fundraising by comparing changes to other technologies a decade ago
Jared Friedman, a Partner in Y Combinator, writes that “that raising money for a biotech or other life science company in 2019 looks a lot like raising money for a tech company 10 years ago.” How is that trend likely to play-out for life science companies over the next decade? He offers his thoughts here.
